These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26066379)

  • 21. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study.
    Luckett T; Allamneni C; Cowley K; Eick J; Gullick A; Peter S
    BMC Gastroenterol; 2018 May; 18(1):67. PubMed ID: 29783927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
    Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
    Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
    Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
    Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
    Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC
    Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
    Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
    Fortun PJ; Anagnostopoulos GK; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey CJ; Ragunath K
    Aliment Pharmacol Ther; 2006 Mar; 23(6):735-42. PubMed ID: 16556175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
    Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference.
    Bibbò S; Ianiro G; Ricci R; Arciuolo D; Petruzziello L; Spada C; Larghi A; Riccioni ME; Gasbarrini A; Costamagna G; Cammarota G
    Dig Liver Dis; 2016 Sep; 48(9):1043-7. PubMed ID: 27436487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm.
    dos Santos RS; Bizekis C; Ebright M; DeSimone M; Daly BD; Fernando HC
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):713-6. PubMed ID: 20074750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barrett's oesophagus: the new endoscopic modalities have a future.
    Deviere J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
    Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
    Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.